Sanofi confirmed that it has been asked by the US Food and Drug Administration to assess the potential neurocognitive side effects of its... ...http://www.medindia.net/news/fda-asks-sanofi-to-assess-potential-neurocognitive-side-effects-of-experimental-cholesterol-drug-132895-1.htm
PRWeb 2014-03-08 MarketResearchReports.Biz announces addition of new report China Orthobiologics Market Outlook To 2020" to its database. Visit:... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=165689
LOS ANGELES (Reuters) - For 33-year-old video editor and hemophilia patient Travis Roop, being able to get life-saving infusions of a blood... ...http://www.dnaindia.com/health/report-new-hemophilia-drugs-deadly-pig-virus-troubled-sleep-study-and-more-health-news-1967737
Pfizer (NYSE:PFE) Intraday Stock Chart Today : Saturday 8 March 2014 By Joseph Walker The U.S. Food and Drug Administration has become aware... ...http://in.advfn.com/p.php?pid=nmona&article=61373192
(Reuters) - The Food and Drug Administration has asked Regeneron and Sanofi to assess potential ...http://www.inooz.in/article/view/2688766/fda-asks-sanofi-regeneron-to-assess-cholesterol-drug-s-cognitive-risks/032014
Radisson Blu Hotel New Delhi Paschim...